These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

914 related items for PubMed ID: 9755153

  • 1. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M, Sieverding C, Dörschner H, Gross I, Aguilar-Bryan L, Schwanstecher C, Bryan J.
    EMBO J; 1998 Oct 01; 17(19):5529-35. PubMed ID: 9755153
    [Abstract] [Full Text] [Related]

  • 2. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
    Dörschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M.
    Mol Pharmacol; 1999 Jun 01; 55(6):1060-6. PubMed ID: 10347249
    [Abstract] [Full Text] [Related]

  • 3. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
    Felsch H, Lange U, Hambrock A, Löffler-Walz C, Russ U, Carroll WA, Gopalakrishnan M, Quast U.
    Br J Pharmacol; 2004 Apr 01; 141(7):1098-105. PubMed ID: 15023854
    [Abstract] [Full Text] [Related]

  • 4. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
    Hambrock A, Löffler-Walz C, Kloor D, Delabar U, Horio Y, Kurachi Y, Quast U.
    Mol Pharmacol; 1999 May 01; 55(5):832-40. PubMed ID: 10220561
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
    Jansen-Olesen I, Mortensen CH, El-Bariaki N, Ploug KB.
    Eur J Pharmacol; 2005 Oct 31; 523(1-3):109-18. PubMed ID: 16226739
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. NMR and fluorescence studies of drug binding to the first nucleotide binding domain of SUR2A.
    López-Alonso JP, de Araujo ED, Kanelis V.
    Biochemistry; 2012 Nov 13; 51(45):9211-22. PubMed ID: 23078514
    [Abstract] [Full Text] [Related]

  • 9. C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.
    Matsuoka T, Matsushita K, Katayama Y, Fujita A, Inageda K, Tanemoto M, Inanobe A, Yamashita S, Matsuzawa Y, Kurachi Y.
    Circ Res; 2000 Nov 10; 87(10):873-80. PubMed ID: 11073882
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
    Hambrock A, Löffler-Walz C, Russ U, Lange U, Quast U.
    Mol Pharmacol; 2001 Jul 10; 60(1):190-9. PubMed ID: 11408614
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
    Shindo T, Yamada M, Isomoto S, Horio Y, Kurachi Y.
    Br J Pharmacol; 1998 Jul 10; 124(5):985-91. PubMed ID: 9692785
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A view of sur/KIR6.X, KATP channels.
    Babenko AP, Aguilar-Bryan L, Bryan J.
    Annu Rev Physiol; 1998 Jul 10; 60():667-87. PubMed ID: 9558481
    [Abstract] [Full Text] [Related]

  • 19. Substitution of the Walker A lysine by arginine in the nucleotide-binding domains of sulphonylurea receptor SUR2B: effects on ligand binding and channel activity.
    Amann T, Schell S, Kühner P, Winkler M, Schwanstecher M, Russ U, Quast U.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun 10; 381(6):507-16. PubMed ID: 20352196
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.